top of page

COLLABORATIONS

​NATIONAL

​​

  • Research Group of Organic Chemistry, Departments of Chemistry and Bioengineering Sciences, Vrije Universiteit Brussel-Belgium (Steven Ballet)

  • In Vivo Cellular and Molecular Imaging, Department of Medical Imaging and Physical Sciences, Vrije Universiteit Brussel-Belgium (Nick Devoogdt)

  • Department of Basic Medical Sciences, Physiology group, Universiteit Gent-Belgium (Luc Leybaert)

  • Basic and Applied Medical Sciences, Gut-Liver Immunopharmacology Unit, Universiteit Gent-Belgium (Lindsey Devisscher)

  • Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, Katholieke Universiteit Leuven-Belgium (Pieter Annaert)

  • Biomecanics Section, GIGA In Silico Medicine, University of Liège-Belgium (Liesbet Geris)

  • Department of Abdominal Surgery and Hepato-Pancreatico-Biliary Surgery, Algemeen Stedelijk Ziekenhuis, Aalst-Belgium (Bert Van Den Bossche)

  • Department of Hepatology and Gastroenterology, Algemeen Stedelijk Ziekenhuis, Aalst-Belgium (Isabelle Colle)

  • Altertox (François Busquet)

  • Janssen Pharmaceutica (Freddy Van Goethem)

Mathieu Vinken Collaborations.jpg

INTERNATIONAL

​

  • Department of Pathology and Immunology and Division of Cardiology, Université de Genève-Switzerland (Brenda Kwak)

  • Translational Research in Cell Communication and Signaling Group, Universidade da Coruña-Spain (Maria Mayan)

  • PROTOQSAR 2000 SL-Spain (Rafael Gozalbes)

  • Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical-USA (Hartmut Jaeschke)

  • Department of Pathology, School of Veterinary Medicine and Animal Science, Universidade de São Paulo-Brazil (Bruno Cogliati)

  • Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri, Milano-Italy (Emilio Benfenati)

  • Department of Biochemistry and Molecular Biology, University of Valencia-Spain, and Experimental Hepatology Unit, IIS Hospital La Fe of Valencia, CIBERehd-Spain (Ramiro Jover)

  • Machine Learning Research, Bayer AG, Berlin-Germany (Djork-Arné Clevert)

  • Department of Toxicogenomics, GROW school for Oncology and Developmental Biology, Maastricht University-The Netherlands (Theo de Kok)

  • Department of Environmental Health, Norwegian Institute of Public Health, Oslo-Norway (Hubert Dirven)

  • Leibniz Research Institute for Environmental Medicine, Düsseldorf-Germany, and Medical Faculty, Heinrich-Heine University, Düsseldorf-Germany (Ellen Fritsche)

  • Center for Alternatives to Animal Testing, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland-USA, and Center for Alternatives to Animal Testing-Europe, University of Konstanz, Konstanz-Germany (Thomas Hartung)

  • Centre of Experimental Medicine SAS, Slovak Academy of Sciences, Bratislava-Slovakia (Helena Kandarova)

  • Institute for Risk Assessment Sciences, Utrecht University, Utrecht-The Netherlands (Nynke Kramer)

  • Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht-The Netherlands (Rosalinde Masereeuw)

  • Innovative Testing in life Sciences and Chemistry, Hogeschool Utrecht University of Applied Sciences Utrecht-The Netherlands (Cyrille Krul)

  • Centre for Health Protection (RIVM), Bilthoven-The Netherlands (Aldert Piersma)

  • ToxTrack, Bethesda, Maryland-USA (Thomas Luechtefeld)

  • 3Rs Management and Consulting ApS, Lyngby-Denmark (Erwin Roggen)

  • esqLABS GmbH, Saterland-Germany (Stephan Schaller)

  • Molecular Networks GmbH, Nürnberg-Germany (Chihae Yang)

​

ALLIANCE RESEARCH GROUPS 

​

  • 2010-2020: “Connexin Signaling Research Group” together with the Department of Basic Medical Sciences, Physiology group, Universiteit Gent-Belgium (Luc Leybaert)

  • Since 2014: “Liver Connexin and Pannexin Research Group” together with the Department of Pathology, School of Veterinary Medicine and Animal Science, Universidade de São Paulo-Brazil (Bruno Cogliati)

​

 RESEARCH VISITS

​

  • In 2002: stay at the Department of Cell Physiology and Metabolism, Université de Genève-Switzerland (Paolo Meda)

  • In 2003: stay at the School of Biosciences, University of Birmingham-United Kingdom (James Chipman)

  • Since 2012: stays at the Department of Pathology, School of Veterinary Medicine and Animal Science, Universidade de São Paulo-Brazil (Bruno Cogliati)

  • In 2014: stay at the Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical-USA (Hartmut Jaeschke)

  • In 2015: stay at the Department of Anatomy and Cell Biology of the University of Western Ontario-Canada (Silvia Penuela)

  • In 2016: stay at the Department of Ophthalmology and New Zealand National Eye Centre, University of Auckland-New Zealand (Colin Green)

​

bottom of page